- Home
- SBFM vs LRHC Comparison
SBFM vs LRHC Comparison
Compare SBFM & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- LRHC
- Stock Information
- Founded
- SBFM 2006
- LRHC 2004
- Country
- SBFM United States
- LRHC United States
- Employees
- SBFM N/A
- LRHC N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- LRHC
- Sector
- SBFM Health Care
- LRHC
- Exchange
- SBFM Nasdaq
- LRHC Nasdaq
- Market Cap
- SBFM 6.5M
- LRHC 5.4M
- IPO Year
- SBFM N/A
- LRHC 2023
- Fundamental
- Price
- SBFM $1.40
- LRHC $5.51
- Analyst Decision
- SBFM Strong Buy
- LRHC
- Analyst Count
- SBFM 1
- LRHC 0
- Target Price
- SBFM $15.00
- LRHC N/A
- AVG Volume (30 Days)
- SBFM 41.6K
- LRHC 337.9K
- Earning Date
- SBFM 08-12-2025
- LRHC 08-18-2025
- Dividend Yield
- SBFM N/A
- LRHC N/A
- EPS Growth
- SBFM N/A
- LRHC N/A
- EPS
- SBFM N/A
- LRHC N/A
- Revenue
- SBFM $36,341,741.00
- LRHC $78,037,079.00
- Revenue This Year
- SBFM $32.20
- LRHC N/A
- Revenue Next Year
- SBFM $32.74
- LRHC N/A
- P/E Ratio
- SBFM N/A
- LRHC N/A
- Revenue Growth
- SBFM 19.22
- LRHC 54.92
- 52 Week Low
- SBFM $1.17
- LRHC $4.33
- 52 Week High
- SBFM $3.90
- LRHC $142.40
- Technical
- Relative Strength Index (RSI)
- SBFM 41.45
- LRHC 42.49
- Support Level
- SBFM $1.36
- LRHC $4.89
- Resistance Level
- SBFM $1.52
- LRHC $5.91
- Average True Range (ATR)
- SBFM 0.07
- LRHC 0.42
- MACD
- SBFM -0.00
- LRHC 0.15
- Stochastic Oscillator
- SBFM 25.00
- LRHC 66.39
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.